The pulmonary protection trial is a randomized , parallel group clinical trial that assesses the effect of pulmonary perfusion with oxygenated blood or Custodiol HTK ( histidine-tryptophan-ketoglutarate ) solution versus no pulmonary perfusion in 90 chronic obstructive pulmonary disease patients .